Sophisticated and simple
New Personalized Therapy Aims to Improve Tamoxifen Effectiveness Breast cancer remains the most common cancer among women worldwide, and hormone receptor–positive cancers account for a…
FDA Grants Fast Track Designation to EO2463 for Follicular Lymphoma The U.S. FDA has granted Fast Track designation to EO2463, a novel immunotherapy from Enterome,…